CVS Health (CVS) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY22 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to CVS Health (CVS) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY22 EPS Guidance

CVS HEALTH REPORTS THIRD QUARTER RESULTS

November 2, 2022 6:30 AM EDT

WOONSOCKET, R.I., Nov. 2, 2022 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2022.

THIRD QUARTER RESULTS

Total revenues increased to $81.2 billion, up 10.0% compared to prior yearGAAP loss per share of $(2.60), inclusive of $5.2 billion pre-tax opioid litigation charges and a $2.5 billion pre-tax loss on assets held for sale related to the Omnicare® long-term care business ("LTC business")Adjusted EPS of $2.09

KEY FINANCIAL DATA

Three Months... More